ORAI2

Across TCGA pan-cancer cohorts, ORAI2 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ORAI2 data layer compared with 20 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher ORAI2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ORAI2 expression acts as an unfavorable survival marker.

SKCM, UCEC, and LUSC are the cancer types where ORAI2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Median	IV	0.415	0.861	.014	9	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUSC	OS	Median	All	0.192	0.724	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ORAI2–SKCM (OS)

Open the SKCM breakdown →